This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1gm2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:37, 7 February 2024) (edit) (undo)
 
(6 intermediate revisions not shown.)
Line 1: Line 1:
-
==THE INDEPENDENT STRUCTURE OF THE ANTITRYPTIC REACTIVE SITE LOOP OF BOWMAN-BIRK INHIBITOR AND SUNFLOWER TRYPSIN INHIBITOR-1==
+
 
-
<StructureSection load='1gm2' size='340' side='right' caption='[[1gm2]], [[NMR_Ensembles_of_Models | 30 NMR models]]' scene=''>
+
==The independent structure of the antitryptic reactive site loop of Bowman-Birk inhibitor and sunflower trypsin inhibitor-1==
 +
<StructureSection load='1gm2' size='340' side='right'caption='[[1gm2]]' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[1gm2]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GM2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1GM2 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[1gm2]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Macrotyloma_axillare Macrotyloma axillare]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GM2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1GM2 FirstGlance]. <br>
-
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1gm2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1gm2 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1gm2 RCSB], [http://www.ebi.ac.uk/pdbsum/1gm2 PDBsum]</span></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1gm2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1gm2 OCA], [https://pdbe.org/1gm2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1gm2 RCSB], [https://www.ebi.ac.uk/pdbsum/1gm2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1gm2 ProSAT]</span></td></tr>
</table>
</table>
-
<div style="background-color:#fffaf0;">
+
== Function ==
-
== Publication Abstract from PubMed ==
+
[https://www.uniprot.org/uniprot/IBB4_MACAX IBB4_MACAX]
-
Bowman-Birk inhibitor (BBI) proteins contain an inhibitory motif comprising a disulfide-bonded sequence that interacts with serine proteinases. Recently, a small 14-residue peptide from sunflowers (SFTI-1), which has potent anti-trypsin activity, has been found to have the same motif. However, this peptide also has an unusual head-to-tail cyclisation. To address the role of the core inhibitory sequence itself, we have solved the (1)H-NMR solution structure of an antitryptic 11-residue cyclic peptide that corresponds to the core reactive site loops of both SFTI-1 and Bowman-Birk inhibitor proteins. A comparison is made between the secondary chemical shifts found in this family and the canonical regions of several other inhibitors, giving some insight into relative flexibility and hydrogen bonding patterns in these inhibitors. The solution structure of the core peptide in isolation is found to retain essentially the same three-dimensional arrangement of both backbone and side chains as observed in larger antitryptic BBI and SFTI-1 fragments as well as in the complete proteins. The retention of the canonical conformation in the core peptide explains the peptids inhibitory potency. It therefore represents a minimization of both the BBI and SFTI-1 sequences. We conclude that the core peptide is a conformationally defined, canonical scaffold, which can serve as a minimal platform for the engineering of biological activity.
+
-
 
+
-
The (1)H-NMR solution structure of the antitryptic core peptide of Bowman-Birk inhibitor proteins: a minimal canonical loop.,Brauer AB, Kelly G, Matthews SJ, Leatherbarrow RJ J Biomol Struct Dyn. 2002 Aug;20(1):59-70. PMID:12144352<ref>PMID:12144352</ref>
+
-
 
+
-
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
+
-
</div>
+
-
== References ==
+
-
<references/>
+
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Brauer, A B.E.]]
+
[[Category: Large Structures]]
-
[[Category: Kelly, G.]]
+
[[Category: Macrotyloma axillare]]
-
[[Category: Leatherbarrow, R J.]]
+
[[Category: Brauer ABE]]
-
[[Category: Matthews, S J.]]
+
[[Category: Kelly G]]
-
[[Category: Bowman-birk inhibitor protein mimetic]]
+
[[Category: Leatherbarrow RJ]]
-
[[Category: Hydrolase inhibitor]]
+
[[Category: Matthews SJ]]
-
[[Category: Trypsin inhibitor]]
+
-
[[Category: Type vib beta-turn peptide]]
+

Current revision

The independent structure of the antitryptic reactive site loop of Bowman-Birk inhibitor and sunflower trypsin inhibitor-1

PDB ID 1gm2

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1gm2"
Personal tools